Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Is implantation of drug-eluting stents a Faustian choice?

Brener SJ.

J Invasive Cardiol. 2010 Oct;22(10):465-6. No abstract available.

2.

[Surgical risk of the patients treated with DES and dual anti-platelet therapy].

Nanto S.

Masui. 2010 Nov;59 Suppl:S1-7. Review. Japanese. No abstract available.

PMID:
21688454
3.

[Expectation for new-generation drug eluting stents].

Saito S.

Nihon Rinsho. 2011 Feb;69(2):237-9. Review. Japanese.

PMID:
21387669
4.

Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

Ducrocq G, Serebruany V, Tanguay JF.

Expert Rev Cardiovasc Ther. 2007 Sep;5(5):939-53. Review.

PMID:
17867923
5.

Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.

Rossini R, Musumeci G, Aprile A, Valsecchi O.

Expert Rev Pharmacoecon Outcomes Res. 2010 Feb;10(1):49-61. doi: 10.1586/erp.10.1. Review.

PMID:
20121564
6.

Off-label use of drug-eluting stents putting it in perspective.

Grines CL.

J Am Coll Cardiol. 2008 Feb 12;51(6):615-7. doi: 10.1016/j.jacc.2007.10.028. Review. No abstract available.

7.

[Stents in interventional cardiology].

Grinius V, Navickas R, Unikas R.

Medicina (Kaunas). 2007;43(3):183-9. Review. Lithuanian.

8.

Safety of drug-eluting stents.

Windecker S, Jüni P.

Nat Clin Pract Cardiovasc Med. 2008 Jun;5(6):316-28. doi: 10.1038/ncpcardio1189. Epub 2008 Apr 15. Review.

PMID:
18414453
9.

Late thrombosis associated with drug-eluting stents.

Derghazarian S, Eisenberg MJ.

Am Heart Hosp J. 2005 Summer;3(3):203-4. Review. No abstract available.

PMID:
16106143
10.

Very late thrombosis of drug-eluting stents: a brief literature review and case example.

Agarwal SK, Shawl F, Raman VK, Binbrek AS.

J Invasive Cardiol. 2008 Dec;20(12):655-8. Review.

11.

Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?

Kumbhani DJ, Bavry AA, Bhatt DL.

Indian Heart J. 2007 Mar-Apr;59(2 Suppl B):B113-7. Review.

PMID:
19153427
12.

Drug-eluting stent thrombosis: an oversensationalized but unresolved problem?

Latib A, Chieffo A, Colombo A.

Monaldi Arch Chest Dis. 2007 Mar;68(1):1-5. Review. No abstract available.

PMID:
17564287
13.

Understanding and minimizing late thrombosis of drug-eluting stents.

Rabbat MG, Bavry AA, Bhatt DL, Ellis SG.

Cleve Clin J Med. 2007 Feb;74(2):129-36. Review. Erratum in: Cleve Clin J Med. 2007 Mar;74(3):238.

PMID:
17333640
14.

[Drug-eluting stents can increase the risk of late stent thrombosis].

Skyttberg N, Linder R, Carlsson J.

Lakartidningen. 2006 Sep 27-Oct 3;103(39):2845-7. Review. Swedish. No abstract available.

PMID:
17128916
15.

Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.

Waksman R, Weinberger J.

Circulation. 2003 Jul 29;108(4):386-8. Review. No abstract available.

16.

Drug-eluting stent thrombosis.

Stähli BE, Camici GG, Tanner FC.

Ther Adv Cardiovasc Dis. 2009 Feb;3(1):45-52. doi: 10.1177/1753944708096280. Epub 2008 Sep 18. Review.

PMID:
19124388
17.

The use of drug-eluting stents in ST-elevation myocardial infarction.

Keong Yeo K, Daemen J, Rogers JH, Serruys PW.

EuroIntervention. 2009 Sep;5(4):494-500. Review.

PMID:
19755339
18.

Intrepide; Trapidil eluting stent.

Khan M, Mhulláin FN, Nolan M.

EuroIntervention. 2008 Nov;4(3):405-11. Review. No abstract available.

PMID:
19110816
19.

Drug-eluting stent safety.

Slottow TL, Waksman R.

Am J Cardiol. 2007 Oct 22;100(8B):10M-17M. Review.

PMID:
17950827
20.

[Results of using the resolute stent in everyday clinical practice in 5000 patients].

Savchenko AP, Rudenko AP, Cherkavskaia OV.

Vestn Rentgenol Radiol. 2010 Aug-Dec;(4):43-7. Review. Russian. No abstract available.

PMID:
22187910

Supplemental Content

Support Center